The mechanisms underlying Dectin-1’s anti-tumoral and pro-tumoral effects are complex, involving various innate and adaptive immune cell types, intercellular interactions, tumor recognition by immune cells, immune cell reprogramming, and microenvironmental regulation. Here, CLEC7A is linked to neoplasm.